Insights

Market Demand Growing need for non-surgical, in-home pelvic health solutions presents a strong opportunity to upsell Flyte System to clinics and women seeking accessible, conservative care for urinary incontinence.

Expansion Readiness Recent next-generation Flyte System launch and ongoing funding momentum indicate readiness for channel expansion, partner onboarding, and greater market penetration with healthcare providers and distributors.

Clinical Validation FDA clearance and published trial data support efficacy and safety, enabling sales conversations with obstetrics/gynecology practices, urology clinics, women's health centers, and hospital systems prioritizing conservative care.

Strategic Partnerships Board and investor activity, including Boomerang Ventures and new board member appointments, signal potential collaboration avenues for distribution, research partnerships, and reimbursement strategy alignment.

Digital Enablement Tech stack and e-commerce readiness (Shopify, digital advertising, analytics) provide scalable marketing and sales enablement opportunities to reach clinicians and patients with targeted campaigns and streamlined purchasing.

Similar companies to Flyte by Pelvital

Flyte by Pelvital Tech Stack

Flyte by Pelvital uses 8 technology products and services including Google Ads, Microsoft Advertising, Microsoft Clarity, and more. Explore Flyte by Pelvital's tech stack below.

Flyte by Pelvital's Email Address Formats

Flyte by Pelvital uses at least 4 email formats:
Flyte by Pelvital Email FormatsExamplePercentage
First@flytetherapy.comJohn@flytetherapy.com
78%
First.Last@flytetherapy.comJohn.Doe@flytetherapy.com
22%
First.Last@pelvital.comJohn.Doe@pelvital.com
92%
First@pelvital.comJohn@pelvital.com
8%

Frequently Asked Questions

What is Flyte by Pelvital's stock symbol?

Minus sign iconPlus sign icon
Flyte by Pelvital is a publicly traded company; the company's stock symbol is 6206.TW.

What is Flyte by Pelvital's official website and social media links?

Minus sign iconPlus sign icon
Flyte by Pelvital's official website is flytesystem.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Flyte by Pelvital generate?

Minus sign iconPlus sign icon
As of August 2026, Flyte by Pelvital's annual revenue is estimated to be $1M - $10M.

What is Flyte by Pelvital's NAICS code?

Minus sign iconPlus sign icon
Flyte by Pelvital's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Flyte by Pelvital have currently?

Minus sign iconPlus sign icon
As of August 2026, Flyte by Pelvital has approximately 16 employees across 4 continents, including North America, South America and Asia. Key team members include Vice President Operations: P. M., Co-Founder Chief Executive Officer Director Investor: D. W. and Regional Territory Director: K. Z. B. Explore Flyte by Pelvital's employee directory with LeadIQ.

What industry does Flyte by Pelvital belong to?

Minus sign iconPlus sign icon
Flyte by Pelvital operates in the Medical Equipment Manufacturing industry.

What technology does Flyte by Pelvital use?

Minus sign iconPlus sign icon
Flyte by Pelvital's tech stack includes Google Ads, Microsoft Advertising, Microsoft Clarity, Visual Website Optimizer, Shopify, Microsoft 365, PayPal and Venmo.

What is Flyte by Pelvital's email format?

Minus sign iconPlus sign icon
Flyte by Pelvital's email format typically follows the pattern of First@flytetherapy.com. Find more Flyte by Pelvital email formats with LeadIQ.

How much funding has Flyte by Pelvital raised to date?

Minus sign iconPlus sign icon
As of August 2026, Flyte by Pelvital has raised $6.8M in funding. The last funding round occurred on Apr 22, 2024 for $2.3M.

When was Flyte by Pelvital founded?

Minus sign iconPlus sign icon
Flyte by Pelvital was founded in 2016.
Flyte by Pelvital logo

Flyte by Pelvital

Medical Equipment ManufacturingMinnesota, United States11-50 Employees

Flyte by Pelvital is a medical device company focused on women's pelvic health, based in Eagan, Minnesota. Its flagship Flyte system has regulatory clearance as a first-line, non-surgical option for female urinary incontinence that can be used at home, with evidence from published trials supporting its effectiveness. The company aims to make effective pelvic health therapies more accessible to both patients and clinicians. Target customers include women with pelvic health disorders and the clinicians who treat them, seeking non-surgical, at-home options that improve care access. In the broader medtech landscape, Flyte operates within the conservative care segment for urinary incontinence, reflecting a shift toward non-invasive management. A recent development is the December 2024 launch of a next-generation Flyte System that adds tools to track patient progress and optimize outcomes.

Section iconCompany Overview

Stock Symbol
6206.TW
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $6.8M

    Flyte by Pelvital has raised a total of $6.8M of funding over 5 rounds. Their latest funding round was raised on Apr 22, 2024 in the amount of $2.3M as a Seed.

  • $1M - $10M

    Flyte by Pelvital's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.